Function of Kv1.5 channels and genetic variations ofKCNA5in patients with idiopathic pulmonary arterial hypertension
Open Access
- 1 May 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 292 (5) , C1837-C1853
- https://doi.org/10.1152/ajpcell.00405.2006
Abstract
The pore-forming α-subunit, Kv1.5, forms functional voltage-gated K+(Kv) channels in human pulmonary artery smooth muscle cells (PASMC) and plays an important role in regulating membrane potential, vascular tone, and PASMC proliferation and apoptosis. Inhibited Kv channel expression and function have been implicated in PASMC from patients with idiopathic pulmonary arterial hypertension (IPAH). Here, we report that overexpression of the Kv1.5 channel gene ( KCNA5) in human PASMC and other cell lines produced a 15-pS single channel current and a large whole cell current that was sensitive to 4-aminopyridine. Extracellular application of nicotine, bepridil, correolide, and endothelin-1 (ET-1) all significantly and reversibly reduced the Kv1.5 currents, while nicotine and bepridil also accelerated the inactivation kinetics of the currents. Furthermore, we sequenced KCNA5 from IPAH patients and identified 17 single-nucleotide polymorphisms (SNPs); 7 are novel SNPs. There are 12 SNPs in the upstream 5′ region, 2 of which may alter transcription factor binding sites in the promoter, 2 nonsynonymous SNPs in the coding region, 2 SNPs in the 3′-untranslated region, and 1 SNP in the 3′-flanking region. Two SNPs may correlate with the nitric oxide-mediated decrease in pulmonary arterial pressure. Allele frequency of two other SNPs in patients with a history of fenfluramine and phentermine use was significantly different from patients who have never taken the anorexigens. These results suggest that 1) Kv1.5 channels are modulated by various agonists (e.g., nicotine and ET-1); 2) novel SNPs in KCNA5 are present in IPAH patients; and 3) SNPs in the promoter and translated regions of KCNA5 may underlie the altered expression and/or function of Kv1.5 channels in PASMC from IPAH patients.Keywords
This publication has 80 references indexed in Scilit:
- Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cellsProceedings of the National Academy of Sciences, 2006
- Pergolide Is an Inhibitor of Voltage-Gated Potassium Channels, Including Kv1.5, and Causes Pulmonary VasoconstrictionCirculation, 2005
- Hypoxic pulmonary vasoconstriction: redox events in oxygen sensingJournal of Applied Physiology, 2005
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Binding of Correolide to the Kv1.3 Potassium Channel: Characterization of the Binding Domain by Site-Directed MutagenesisBiochemistry, 2001
- Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage‐gated potassium channel Kv1.5The FASEB Journal, 2001
- Phosphorylation Is Required for Alteration of Kv1.5 K+ Channel Function by the Kvβ1.3 SubunitJournal of Biological Chemistry, 1999
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Functional Differences in Kv1.5 Currents Expressed in Mammalian Cell Lines Are Due to the Presence of Endogenous Kvβ2.1 SubunitsPublished by Elsevier ,1996
- Inactivation properties of voltage-gated K+ channels altered by presence of β-subunitNature, 1994